SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-19-265898
Filing Date
2019-10-10
Accepted
2019-10-10 16:55:07
Documents
2
Group Members
COLUMN GROUP GP, LPDAVID V. GOEDDELPETER SVENNILSONPONOI CAPITAL II, LPPONOI CAPITAL, LPPONOI II MANAGEMENT, LLCPONOI MANAGEMENT, LLCTIM KUTZKEY

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d813535dsc13ga.htm SC 13G/A 160328
2 EX-99.1 d813535dex991.htm EX-99.1 17799
  Complete submission text file 0001193125-19-265898.txt   179874
Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 415-865-2050
COLUMN GROUP L P (Filed by) CIK: 0001347769 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A

Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Subject) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90572 | Film No.: 191146552
SIC: 2834 Pharmaceutical Preparations